Skip to content

Exagen Inc. XGN Property, plant and equipment

Property, plant and equipment at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-28.2%
Enterprise value$117.78M-22.1%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s property, plant and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s property, plant and equipment?
Exagen Inc. (XGN) reported property, plant and equipment of $3.7M in Q1 2026.
How has Exagen Inc.'s property, plant and equipment changed year-over-year?
Exagen Inc.'s property, plant and equipment increased by 208.3% year-over-year, from $1.2M to $3.7M.
What is the long-term trend for Exagen Inc.'s property, plant and equipment?
Over 2 years (2023 to 2025), Exagen Inc.'s property, plant and equipment has grown at a 21.7% compound annual growth rate (CAGR), from $2.5M to $3.7M.